Back to MDGL
Candriam S.C.A. MDGL Position History
Madrigal Pharmaceuticals, Inc. • Healthcare
Quarters held
6
Latest value
$34.8M
Q3 2026
Peak value
$44.5M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $22.9M |
| Q4 2025 | $37.2M |
| Q4 2025 | $37.2M |
| Q1 2026 | $44.5M |
| Q2 2026 | $38.7M |
| Q3 2026 | $34.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $34.8M | 68.8K | — | — |
| Q2 2026 | $38.7M | 72.1K | — | — |
| Q1 2026 | $44.5M | 84.9K | — | — |
| Q4 2025 | $37.2M | 63.9K | — | — |
| Q4 2025 | $37.2M | 63.9K | — | — |
| Q3 2025 | $22.9M | 50.0K | — | — |
Other funds holding MDGL
$728.8M
$719.5M
$319.1M
$283M
$283M
$237.6M
$212.9M
$212.9M